{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:09:59Z","timestamp":1789456199920,"version":"build-2803163510"},"reference-count":38,"publisher":"SAGE Publications","issue":"12","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Lupus"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hypertension is prevalent and contributes significantly to cardiovascular risk in patients with systemic lupus erythematosus (SLE). Primary aldosteronism (PA), the most common endocrine cause of hypertension, confers higher cardiovascular risk than essential hypertension and has been linked to autoimmune diseases including SLE. While the prevalence of PA in SLE is unknown, a third of patients in a tertiary lupus clinic have been demonstrated to have clinical indications for PA testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To compare SLE phenotypes and outcomes in patients attending the clinic with and without indications for PA testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective study, hypertension was defined as blood pressure \u2265140\/90 on two clinic visits, or a documented diagnosis of hypertension. Baseline demographic and SLE disease characteristics were compared between patients with and without an indication for PA testing as determined according to the 2016 Endocrine Society guidelines, before multivariable regression analyses assessed for associations between having an indication for PA testing with disease phenotypes and outcomes specifically within the subset of patients with hypertension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 322 patients with SLE, 95 patients (30%) had at least one indication for PA testing. These patients were older, had longer SLE disease duration, higher body mass index, higher blood pressure, and more baseline organ damage compared to those without an indication for PA testing. Over the period of clinic attendance (median 6.8\u00a0years), these patients had greater accrual of organ damage, higher flare rates, and more frequent proteinuria. Within the subset of hypertensive patients, indications for PA testing were independently associated with reduced baseline renal function (adjusted OR 3.29, 95% CI 1.30\u20139.47\n                      <jats:italic toggle=\"yes\">; p<\/jats:italic>\n                      = 0.017), higher baseline organ damage (adjusted OR 1.94, 95% CI 1.03\u20133.73\n                      <jats:italic toggle=\"yes\">; p<\/jats:italic>\n                      = 0.043), and higher prevalence of flare throughout the study period (adjusted OR 2.86, 95% CI 1.04\u20138.60;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.049) in multivariable modelling.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>SLE patients with an indication for PA testing exhibit a phenotype characterised by impaired renal function, increased organ damage and higher prevalence of flare. Further research is needed to prospectively assess whether the increased burden is attributable to PA, other causes of hypertension, or the severe hypertension.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/09612033261473968","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T07:00:29Z","timestamp":1785481229000},"page":"1308-1319","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical phenotypes and disease outcomes of patients with systemic lupus erythematosus meeting indication for primary aldosteronism testing"],"prefix":"10.1177","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0799-6052","authenticated-orcid":false,"given":"Matthew","family":"Wong","sequence":"first","affiliation":[{"name":"Monash University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Akram","sequence":"additional","affiliation":[{"name":"Hudson Institute of Medical Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna R.","family":"Kent","sequence":"additional","affiliation":[{"name":"Monash Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Fuller","sequence":"additional","affiliation":[{"name":"Hudson Institute of Medical Research"},{"name":"Monash Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9416-7383","authenticated-orcid":false,"given":"Alberta Y.","family":"Hoi","sequence":"additional","affiliation":[{"name":"Monash Health"},{"name":"Monash University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[{"name":"Monash University"},{"name":"Hudson Institute of Medical Research"},{"name":"Monash Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien B.","family":"Vincent","sequence":"additional","affiliation":[{"name":"Monash University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"e_1_3_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00398-2"},{"key":"e_1_3_7_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000528"},{"key":"e_1_3_7_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.142737"},{"key":"e_1_3_7_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-015-3316-z"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.101132"},{"key":"e_1_3_7_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04211.x"},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23880"},{"key":"e_1_3_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102371"},{"key":"e_1_3_7_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002300"},{"key":"e_1_3_7_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2007.33"},{"key":"e_1_3_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30319-4"},{"key":"e_1_3_7_13_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-4061"},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2021.0254"},{"key":"e_1_3_7_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.025952"},{"key":"e_1_3_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2019.05.087"},{"key":"e_1_3_7_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2025-001524"},{"key":"e_1_3_7_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400928"},{"key":"e_1_3_7_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.34473"},{"key":"e_1_3_7_20_2","doi-asserted-by":"publisher","DOI":"10.5694\/mja16.01282"},{"key":"e_1_3_7_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu153"},{"key":"e_1_3_7_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2019-000375"},{"key":"e_1_3_7_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2019-000372"},{"issue":"9","key":"e_1_3_7_24_2","first-page":"1977","article-title":"Summarizing disease features over time: I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupus","volume":"30","author":"Ibanez D","year":"2003","unstructured":"Ibanez D, Urowitz MB, Gladman DD. Summarizing disease features over time: I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupus. J Rheumatol 2003; 30(9): 1977\u20131982.","journal-title":"J Rheumatol"},{"key":"e_1_3_7_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051135"},{"issue":"2","key":"e_1_3_7_26_2","first-page":"373","article-title":"The systemic lupus international collaborating clinics\/American College of Rheumatology (SLICC\/ACR) damage index for systemic Lupus erythematosus international comparison","volume":"27","author":"Gladman DD","year":"2000","unstructured":"Gladman DD, Goldsmith CH, Urowitz MB, et al. The systemic lupus international collaborating clinics\/American College of Rheumatology (SLICC\/ACR) damage index for systemic Lupus erythematosus international comparison. J Rheumatol 2000; 27(2): 373\u2013376.","journal-title":"J Rheumatol"},{"key":"e_1_3_7_27_2","volume-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2025","unstructured":"R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, 2025."},{"key":"e_1_3_7_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-019-0244-2"},{"issue":"11","key":"e_1_3_7_29_2","first-page":"2312","article-title":"Primary aldosteronism: an unsuspected culprit of hypertension in systemic lupus erythematosus?","volume":"41","author":"Feng GS","year":"2023","unstructured":"Feng GS, Kent JR, Fuller PJ, et al. Primary aldosteronism: an unsuspected culprit of hypertension in systemic lupus erythematosus? Clin Exp Rheumatol 2023; 41(11): 2312\u20132322. https:\/\/doi.org\/10.55563\/clinexprheumatol\/h58aqe","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_7_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.03936"},{"key":"e_1_3_7_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.123.21474"},{"key":"e_1_3_7_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24494"},{"key":"e_1_3_7_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2020-000427"},{"key":"e_1_3_7_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.32190"},{"key":"e_1_3_7_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-34022-0"},{"key":"e_1_3_7_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20002"},{"key":"e_1_3_7_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-58463-3"},{"key":"e_1_3_7_38_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203318759607"},{"key":"e_1_3_7_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002960050112"}],"container-title":["Lupus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09612033261473968","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/09612033261473968","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09612033261473968","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:34:58Z","timestamp":1789454098000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/09612033261473968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1177\/09612033261473968"],"URL":"https:\/\/doi.org\/10.1177\/09612033261473968","relation":{},"ISSN":["0961-2033","1477-0962"],"issn-type":[{"value":"0961-2033","type":"print"},{"value":"1477-0962","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]}}}